Emerald Bioscience Appoints Chief Medical Officer and Executive Director, Clinical Operations

NEXT STORY
Therapeutic Solutions International Announces Positive Clinical Data Using NanoStilbene™ to Stimulate Immune System in Advanced Cancer Patients
PREV STORY
PreCheck Health Services Signs Additional Binding Agreement to Acquire Companies to Strengthen Its Point-of-Care Medical Screening Capabilities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017

MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its ...

author_avatar
NASDAQ Market News

Moleculin to Begin Clinical Trials at UMC Southwest Cancer Center

HOUSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the ...

author_avatar
NASDAQ Market News

Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2016

DUBLIN, Ireland, Feb. 16, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics ...

author_avatar
NASDAQ Market News